Rabe Klaus F, Hurd Suzanne, Anzueto Antonio, Barnes Peter J, Buist Sonia A, Calverley Peter, Fukuchi Yoshinosuke, Jenkins Christine, Rodriguez-Roisin Roberto, van Weel Chris, Zielinski Jan
Leiden University Medical Center, Pulmonology, P.O. Box 9600, NL-2300 RC, Leiden, The Netherlands.
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is the fourth leading cause of chronic morbidity and mortality in the United States, and is projected to rank fifth in 2020 in burden of disease worldwide, according to a study published by the World Bank/World Health Organization. Yet, COPD remains relatively unknown or ignored by the public as well as public health and government officials. In 1998, in an effort to bring more attention to COPD, its management, and its prevention, a committed group of scientists encouraged the U.S. National Heart, Lung, and Blood Institute and the World Health Organization to form the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Among the important objectives of GOLD are to increase awareness of COPD and to help the millions of people who suffer from this disease and die prematurely of it or its complications. The first step in the GOLD program was to prepare a consensus report, Global Strategy for the Diagnosis, Management, and Prevention of COPD, published in 2001. The present, newly revised document follows the same format as the original consensus report, but has been updated to reflect the many publications on COPD that have appeared. GOLD national leaders, a network of international experts, have initiated investigations of the causes and prevalence of COPD in their countries, and developed innovative approaches for the dissemination and implementation of COPD management guidelines. We appreciate the enormous amount of work the GOLD national leaders have done on behalf of their patients with COPD. Despite the achievements in the 5 years since the GOLD report was originally published, considerable additional work is ahead of us if we are to control this major public health problem. The GOLD initiative will continue to bring COPD to the attention of governments, public health officials, health care workers, and the general public, but a concerted effort by all involved in health care will be necessary.
慢性阻塞性肺疾病(COPD)仍然是一个主要的公共卫生问题。它是美国慢性发病和死亡的第四大主要原因,根据世界银行/世界卫生组织发表的一项研究,预计到2020年它将在全球疾病负担中排名第五。然而,COPD仍然相对不为公众以及公共卫生和政府官员所知或被忽视。1998年,为了使更多人关注COPD、其管理和预防,一群坚定的科学家鼓励美国国立心肺血液研究所和世界卫生组织成立慢性阻塞性肺疾病全球倡议组织(GOLD)。GOLD的重要目标之一是提高对COPD的认识,并帮助数百万患有这种疾病并过早死于该病或其并发症的人。GOLD计划的第一步是编写一份共识报告《慢性阻塞性肺疾病诊断、管理和预防全球策略》,该报告于2001年发表。目前新修订的文件沿用了原始共识报告的相同格式,但已进行更新以反映已出现的众多关于COPD的出版物。GOLD各国负责人,一个国际专家网络,已经在其国家开展了对COPD病因和患病率的调查,并开发了传播和实施COPD管理指南的创新方法。我们感谢GOLD各国负责人为其COPD患者所做的大量工作。尽管自GOLD报告首次发表以来的5年里取得了一些成就,但如果我们要控制这一主要公共卫生问题,仍有大量额外工作要做。GOLD倡议将继续使政府、公共卫生官员、医护人员和公众关注COPD,但所有参与医疗保健的人员必须齐心协力。